Dyne Therapeutics

Dyne Therapeutics

Biotechnology Research Waltham, Massachusetts, United States 227 employees
Employees
227
Contacts
3
Emails
3
Phones
3

Dyne Therapeutics Overview

Headquarters
Waltham, Massachusetts, United States
Website
dyne-tx.com
Industry
Biotechnology Research
Employees
227
Founded
2018
Funding
230.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords

About Dyne Therapeutics

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and preclinical programs for facioscapulohumeral muscular dystrophy (FSHD) and Pompe disease. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more https://www.dyne-tx.com/. To view our community guidelines, click here: https://bit.ly/3BYPnpK

Dyne Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
3
75.0% coverage

Dyne Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Michael Tobin VP, Head of Technology at Dyne
Email Phone
Marcel Meth Sharepoint Consultant/developer/analyst
View
Clarence J. Wang VP, Head of Data Sciences
Email Phone
Jason Rhodes
Email Phone

Employees by Management Level

Individual contributor 10 profiles
Executive 4 profiles
Director 4 profiles
Manager 4 profiles
VP / Head 3 profiles
Senior / Lead 3 profiles

Department Contact Coverage

Department Contacts Email Phone
General 5 5 1
Healthcare 3 3 0
Executive 2 2 1
Finance 1 1 1
IT 1 1 0

Dyne Therapeutics Tech Stack

Data / AI 7 profiles
Engineering 1 profile

Compare Similar Companies to Dyne Therapeutics